Subsequent Events

12 Months Ended

Dec. 31, 2018

Subsequent Events

Subsequent Events

18. Subsequent Events

In January 2018, the Company issued an aggregate of 225,909 shares of its common stock to Broad as payment of all outstanding principal and interest under the December Success Payment Notes (see Note 8). Upon such issuance and payment, the December Success Payment Notes were cancelled.

In January 2018, the Company issued an aggregate of 80,000 shares of its common stock to MGH in connection with settling the First MGH Success Payment (see Note 8).

In January 2018, the Company paid $1.6 million in cash and issued an aggregate of 56,099 shares of its common stock, valued at $29.76 per share, to i2 Pharmaceuticals, Inc. in connection with the purchase of certain assets pursuant to an asset purchase agreement. 

In January 2018, the Company sold an aggregate of 1,429,205 common shares under the March 2017 ATM Program at an average price of $34.99 per common share for gross proceeds of $50.0 million. The March 2017 ATM Program was fully utilized in January 2018.